An ophthalmic surgeon reported that two days following an intraocular lens (iol) implant procedure, a patient developed inflammation.The symptoms started to improve after about a week of steroid eye drop treatment.The patient has atopic syndrome, although it is unknown if it had any relation with the event.The lens remains implanted.There was no indication that a bacterium inspection was performed.Additional information has been requested.
|
Evaluation summary: a voluntary recall of acrysof restor® and restor® toric iol models occurred on april 16, 2015, after an increased number of complaints of ocular inflammation post cataract surgery.Following the announcement of the recall, reports of post-surgical ocular inflammation for non recall lenses in (b)(6) were also received.It is not unusual to expect the number of complaints to increase following such an announcement as there is heightened awareness of the event.The increase in complaints observed for the non recall models is specific to the (b)(4) market.Based on the interpretation that this increase in the number of reports of post-surgical ocular inflammation for the non recall models is below the published rates (oshika t, et al.Incidence of endophthalmitis following cataract surgery in japan.Acta ophthalmol.Scand 2007:85:848-851), we will continue to closely monitor for any potential trends or signals.Based on continued trending of all acrysof® models the acrysof® iq toric sn6at6, sn6at7, sn6at8 and sn6at9 intraocular lenses (iols) for the (b)(4) market were added to the voluntary recall (29-sep-2015).(b)(4).
|